Status:
UNKNOWN
A Clinical Follow-up Study of Heart Failure Patients.
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Heart Failure
Eligibility:
All Genders
15-80 years
Brief Summary
Heart failure (HF), a current worldwide pandemic with an unacceptable high level of morbidity and mortality, brings an enormous medical and societal burden. Chronic HF is characterized by progressive ...
Eligibility Criteria
Inclusion
- LVEF≤ 55%
- enlarged left ventricular end-diastolic dimension
- ICM group: with history of MI or revascularization; ≥ 75% stenosis of LM or proximal LAD; ≥ 75% stenosis of two or more epicardial vessels.
- symptomatic heart failure
Exclusion
- Known malignant tumour diseases
- Pregnancy or lactation period；
- Investigators think not suitable to participate in this trial.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03797742
Start Date
January 1 2018
End Date
December 1 2022
Last Update
January 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Hospital
Shanghai, China